Advertisement

Regulation of NK Cell Functions Through Interaction of the CD94/NKG2 Receptors with the Nonclassical Class I Molecule HLA-E

  • V. M. Braud
  • A. J. McMichael
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 244)

Abstract

Natural killer (NK) cells constitute 5%–20% of the lymphocyte population in the periphery. They are cytotoxic, but also secrete cytokines. They play a major role in innate immunity, as an early defense against a variety of infections and influence the development of acquired immunity. They also participate in the elimination of certain tumors and virally infected cells which have lost or downregulated their MHC class I molecules. This concept was originally proposed by Kärre as “the missing self hypothesis” (Kärre 1997). The cytotoxic activity of NK cells is regulated by cell surface receptors for MHC class I molecules that can deliver activatory or inhibitory signals. The characterization of these receptors has considerably increased in the last few years (Lanier 1998). They are generally classified into two main families: the immunoglobulin superfamily and the C-type lectin superfamily. In humans, NK receptors belonging to the Ig superfamily can recognize groups of HLA class I molecules, such as two distinct groups of HLA-C alleles (KIR2DL1, KIR2DL2, KIR2DL3, KIR2DS1, KIR2DS2), one group of B alleles displaying Bw4 supertypic specificity (KIR3DL1), and the HLA-A alleles, HLA-A3 and HLA-A11 (KIR3DL2). CD94/NKG2 heterodimers belong to the C-type lectin superfamily and were thought to recognize most HLA class I molecules.

Keywords

Natural Killer Cell Leader Sequence Leader Peptide Transporter Associate With Antigen Processing Classical Class 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aldrich CJ, DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J (1994) Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79: 649–658PubMedCrossRefGoogle Scholar
  2. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from NK-cell-mediated lysis. J Exp Med 187:813–818PubMedCrossRefGoogle Scholar
  3. Braud V, Jones EY, McMichael A (1997) The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27:1164–1169PubMedCrossRefGoogle Scholar
  4. Braud VM, Allan DSJ, O’Callaghan CA, Soderstrom K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998a) HLA-E binds to natural killer cell receptors CD94/NKG2 A, B, and C. Nature 391:795–799PubMedCrossRefGoogle Scholar
  5. Braud VM, Allan DSJ, Wilson D, McMichael AJ (1998b) TAP-and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 8:1–10PubMedCrossRefGoogle Scholar
  6. Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE (1997) NKG2 A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 185:795–800PubMedCrossRefGoogle Scholar
  7. Burshtyn DN, Long EO (1997) Regulation through inhibitory receptors: lessons from natural killer cells. Trends. Cell Biol 7:473–479PubMedCrossRefGoogle Scholar
  8. Cantoni C, Biassoni R, Pende D, Sivori S, Accame L, Pareti L, Semenzato G, Moretta L, Moretta A, Bottino C (1998) The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol 28:327–338PubMedCrossRefGoogle Scholar
  9. Carena I, Shamshiev A, Donda A, Colonna M, De Libero G (1997) Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ stimulated by nonpeptidic ligands. J Exp Med 186:1769–1774PubMedCrossRefGoogle Scholar
  10. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodriguez A, Perez-Villar JJ, Moretta A, Lopez-Botet M (1997) The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 27:563–567PubMedCrossRefGoogle Scholar
  11. Carretero M, Palmieri G, Liano M, Tullio V, Santoni A, Geraghty DE, Lopez-Botet M (1998) Specific engagement of the CD94/NKG2 A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2 A: evidence for receptor function in heterologous transfectants. Eur J Immunol 28:1280–1291PubMedCrossRefGoogle Scholar
  12. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC (1997) Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 158:3603–3609PubMedGoogle Scholar
  13. Kärre K (1997) How to recognize a foreign submarine. Immunol Rev 155:5–9PubMedCrossRefGoogle Scholar
  14. Knapp LA, Cadavid LF, Watkins DI (1998) The MHC-E locus is the most well conserved of all known primate class I histocompatibility genes. J Immunol 160:189–196PubMedGoogle Scholar
  15. Lanier LL (1998) NK cell receptors. Annu Rev Immunol 16:359–393PubMedCrossRefGoogle Scholar
  16. Lanier LL, Corliss B, Wu J, Phillips JH (1998a) Association of DAP12 with activating CD94/NKG2 C NK cell receptors. Immunity 8:693–701PubMedCrossRefGoogle Scholar
  17. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH (1998b) Immunoreceptor DAP 12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703–707PubMedCrossRefGoogle Scholar
  18. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH (1996) Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741–4745PubMedGoogle Scholar
  19. Le Drean E, Vely F, Olcese L, Cambiaggi A, Guia S, Krystal G, Gervois N, Moretta A, Jotereau F, Vivier E (1998) Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2 A: association of NKG2 A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol 28:264–276PubMedCrossRefGoogle Scholar
  20. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE (1998a) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160:4951–4960PubMedGoogle Scholar
  21. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE (1998b) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2 A. Proc Natl Acad Sci USA 95:5199–5204PubMedCrossRefGoogle Scholar
  22. Lyko F, Martoglio B, Jungnickel B, Rapoport TA, Dobberstein B (1995) Signal sequence processing in rough microsomes. J Biol Chem 270:19873–19878PubMedCrossRefGoogle Scholar
  23. O’Callaghan CA, Tormo J, Willcox BE, Braud VM, Jakobsen BK, Stuart DI, McMichael AJ, Bell JI, Jones EY (1998) Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Molecular Cell 1:531–541PubMedCrossRefGoogle Scholar
  24. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E (1997) Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158:5083–5086PubMedGoogle Scholar
  25. Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A (1997) HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 27:1875–1880PubMedCrossRefGoogle Scholar
  26. Perez Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, Colonna M, Geraghty DE, Lopez Botet M (1997) The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 158:5736–5743PubMedGoogle Scholar
  27. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL (1996) CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B and HLA-C allotypes. Immunity 5:163–172PubMedCrossRefGoogle Scholar
  28. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A (1996) CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 26:2487–2492PubMedCrossRefGoogle Scholar
  29. Soderstrom K, Corliss B, Lanier LL, Phillips JH (1997) CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 159:1072–1075PubMedGoogle Scholar
  30. Ulbrecht M, Kellermann J, Johnson JP, Weiss EH (1992) Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding. J Exp Med 176:1083–1090PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • V. M. Braud
    • 1
  • A. J. McMichael
    • 1
  1. 1.Institute of Molecular MedicineHeadington, OxfordUK

Personalised recommendations